武汉发布112项核心医疗技术成果

Core Insights - Wuhan has launched its first batch of core medical technologies, marking a significant step in establishing itself as an international medical innovation hub [1] - A total of 112 core medical technologies were released, with 617 projects submitted by 39 medical institutions during the evaluation process [1][2] - The technologies span various fields, showcasing high competitiveness in organ transplantation, gastrointestinal diseases, gynecological tumors, and cardiovascular diseases [1] Technology Classification - The 112 core medical technologies are categorized into three groups: - 32 "Leading Technologies" represent breakthrough innovations, including the globally recognized Chen's liver blood flow blockade method and the world's lightest artificial heart technology [2] - 40 "Pioneering Technologies" focus on improving traditional methods to address significant medical challenges, such as a corneal transplant technique that treats three patients with one donated cornea [2] - 40 "Fundamental Technologies" target common diseases and are suitable for widespread use in primary healthcare settings, like the "super minimally invasive" technique for immediate stone removal [2] Support Measures - The Wuhan Municipal Health Commission will implement support measures for the selected 112 core medical technologies, including platform development, insurance policies, professional title promotions, funding, and promotional activities [2]